1,200
Participants
Start Date
May 31, 2006
5- Fluorouracil (5-FU)
bevacizumab (Avastin)
Leucovorin
CoFactor (ANX-510)
Mercy General Hospital, Sacramento
Research Center In, Florence
Research Center In, Anaheim
Research Center In, Apple Valley
Research Center In, Beverly Hills
Research Center In, Irvine
Research Center In, Mission Hills
Research Center In, Poway
Research Center In, Rancho Mirage
Research Center In, Sacramento
Research Center In, San Diego
Research Site In, San Diego
Research Center In, Vista
Research Center In, Boynton Beach
Research Center In, Merritt Island
Research Center In, Port Saint Lucie
Research Center In, Tarpon Springs
Research Center In, Gurnee
Research Center In, Joliet
Research Center In, Skokie
Research Center In, Indianapolis
Research Center In, Wichita
Research Center In, Hazard
Research Center In, Baltimore
Research Center In, Flint
Research Center In, Free Soil
Research Center In, Grand Rapids
Research Center In, Port Huron
Research Center In, Jackson
Research Center In, Henderson
Research Center In, Las Vegas
Research Center In, Reno
Research Center In, Cherry Hill
Research Center In, Farmington
Research Center In, East Setauket
Research Center In, Greenville
Research Center In, Middletown
Research Center In, Cranston
Research Center In, Charleston
Research Center In, Columbia
Research Center In, Chattanooga
Research Center In, Collierville
Research Center In, Fort Worth
Research Center In, Ogden
Research Center In, Lacey
Research Center In, Walla Walla
Research Center In, Zrenjanin
Lead Sponsor
Mast Therapeutics, Inc.
INDUSTRY